BSE Live
Nov 17, 16:00Prev. Close
428.85
Open Price
410.00
Bid Price (Qty.)
428.85 (3881)
Offer Price (Qty.)
431.00 (1)
NSE Live
Nov 17, 15:57Prev. Close
428.55
Open Price
410.60
Bid Price (Qty.)
428.55 (4656)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Shasun Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 1,284.34 | 1,185.62 | 1,051.42 | 1,034.40 | 804.61 | |
| Less: Excise/Sevice Tax/Other Levies | 35.03 | 31.13 | 24.52 | 19.48 | 13.82 | |
| Revenue From Operations [Net] | 1,249.30 | 1,154.49 | 1,026.90 | 1,014.92 | 790.79 | |
| Total Operating Revenues | 1,316.63 | 1,212.69 | 1,084.77 | 1,066.40 | 834.45 | |
| Other Income | 12.23 | 22.94 | 18.28 | 40.92 | 21.97 | |
| Total Revenue | 1,328.86 | 1,235.62 | 1,103.05 | 1,107.32 | 856.42 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 672.02 | 619.23 | 564.69 | 558.57 | 451.56 | |
| Purchase Of Stock-In Trade | 6.31 | 9.60 | 1.77 | 5.23 | 6.26 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | 2.29 | -17.85 | -20.55 | -2.40 | -26.01 | |
| Employee Benefit Expenses | 236.36 | 216.35 | 186.64 | 159.41 | 143.20 | |
| Finance Costs | 52.53 | 41.51 | 32.19 | 43.70 | 32.26 | |
| Depreciation And Amortisation Expenses | 46.96 | 59.36 | 52.65 | 40.57 | 37.58 | |
| Other Expenses | 290.06 | 284.46 | 235.26 | 222.63 | 187.97 | |
| Total Expenses | 1,306.53 | 1,212.66 | 1,052.66 | 1,027.69 | 832.82 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 22.32 | 22.97 | 50.40 | 79.63 | 23.60 | |
| Exceptional Items | 7.85 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 30.17 | 22.97 | 50.40 | 79.63 | 23.60 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 13.83 | 5.55 | 1.46 | 6.17 | 2.14 | |
| Less: MAT Credit Entitlement | 11.98 | 5.55 | 1.49 | 10.52 | 0.00 | |
| Deferred Tax | 4.25 | -0.30 | -2.61 | -16.59 | -5.17 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 6.33 | -7.27 | -2.64 | -20.93 | -3.03 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 23.84 | 30.24 | 53.04 | 100.57 | 26.62 | |
| Profit/Loss From Continuing Operations | 23.84 | 30.24 | 53.04 | 100.57 | -14.14 | |
| Profit/Loss For The Period | 23.84 | 30.24 | 53.04 | 100.57 | -14.14 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 23.76 | 30.21 | 53.04 | 100.57 | -14.14 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 4.00 | 5.00 | 10.00 | 21.00 | -3.00 | |
| Diluted EPS (Rs.) | 4.00 | 5.00 | 10.00 | 20.00 | -3.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 5.66 | 8.49 | 11.91 | 1.46 | |
| Tax On Dividend | 0.00 | 0.96 | 1.44 | 1.93 | 0.24 |